ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > ProS1

ProS1

概要

Name:Prostate-specific antigen
Target Synonym:P-30 antigen,Semenogelase,APS,Prostate-specific antigen,PSA,Kallikrein Related Peptidase 3,Gamma-Seminoprotein,Kallikrein-3,Seminin,Kallikrein 3, (Prostate Specific Antigen),EC 3.4.21.77,KLK2A1,HK3,KLK3,EC 3.4.21,EC:3.4.21.77
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:5
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
タグ別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
PR1-H52H4 Human Human ProS1 Protein, His Tag
PR1-H52H4-structure
PR1-H52H4-sds
PR1-H52H3 Human Human ProS1 Protein, His Tag
PR1-H52H3-structure
PR1-H52H3-sds
ACRO Quality

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Afala Approved Materia Medica Holding Research And Production Company Russian Federation Prostatic Neoplasms; Prostatitis Materia Medica Holding Research And Production Company 2014-01-01 Prostatic Neoplasms; Prostatitis Details
Afala Approved Materia Medica Holding Research And Production Company Russian Federation Prostatic Neoplasms; Prostatitis Materia Medica Holding Research And Production Company 2014-01-01 Prostatic Neoplasms; Prostatitis Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
Prostate cancer vaccine (Advaxis) ADXS-PSA; ADXS-31142 Phase 2 Clinical Advaxis Inc Neoplasms; Prostatic Neoplasms Details
TP-122A TP-122A Phase 2 Clinical Vector B2B, Technophage SA Pneumonia, Ventilator-Associated Details
GEA-408 GEA-408 Phase 2 Clinical GenEros Biopharma Hangzhou Ltd Prostatic Neoplasms Details
P-PSMA-101 P-PSMA-101 Phase 1 Clinical Poseida Therapeutics Inc Genital Neoplasms, Male; Salivary Gland Neoplasms; Neoplasms; Carcinoma, Adenoid Cystic; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Carcinoma, Mucoepidermoid; Carcinoma, Acinar Cell; Urogenital Neoplasms; Prostatic Diseases Details
Prostate cancer subunit vaccine (Progenics) Phase 1 Clinical Progenics Pharmaceuticals Inc Prostatic Neoplasms Details
Prostate cancer vaccine (Advaxis) ADXS-PSA; ADXS-31142 Phase 2 Clinical Advaxis Inc Neoplasms; Prostatic Neoplasms Details
TP-122A TP-122A Phase 2 Clinical Vector B2B, Technophage SA Pneumonia, Ventilator-Associated Details
GEA-408 GEA-408 Phase 2 Clinical GenEros Biopharma Hangzhou Ltd Prostatic Neoplasms Details
P-PSMA-101 P-PSMA-101 Phase 1 Clinical Poseida Therapeutics Inc Genital Neoplasms, Male; Salivary Gland Neoplasms; Neoplasms; Carcinoma, Adenoid Cystic; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms; Carcinoma, Mucoepidermoid; Carcinoma, Acinar Cell; Urogenital Neoplasms; Prostatic Diseases Details
Prostate cancer subunit vaccine (Progenics) Phase 1 Clinical Progenics Pharmaceuticals Inc Prostatic Neoplasms Details

This web search service is supported by Google Inc.

totopphone